Google and big names helped Oxford Sciences Innovation to raise €457M
Oxford Sciences Innovation has completed the second close of its fundraising, raising an additional €157.3M…
June 28, 2015 - 2 minutes
What’s new
AstraZeneca’s senior managers are abandoning ship
In just a couple of weeks, AstraZeneca has seen two of its chiefs leave their position…
June 25, 2015 - 2 minutes
BioNTech and Siemens to build a new Production plant for Personalized Cancer Vaccines
Personalized medicine is the next thing and immunotherapy expert BioNTech is determined to build its…
June 25, 2015 - 1 minute
Video: Discover How CAR-T Therapies are Working
It's becoming a habit for us to talk about CAR-T therapies. It's basically the next…
June 25, 2015 - 1 minute
A treatment for Spinal Muscular Atrophy received Orphan Drug designation
The European Medicines Agency has granted Orphan Drug designation to AveXis’ gene transfer candidate. The…
June 25, 2015 - 1 minute
AYOXXA and Grünenthal collaborate on inflammation markers
AYOXXA Biosystems and Grünenthal have completed their first research collaboration to validate detection limits for…
June 24, 2015 - 2 minutes
DBV Technologies to cure Peanut allergy
DBV Technologies plans the initiation of its phase III clinical trial for Viaskin Peanut, after…
June 23, 2015 - 2 minutes
Chris Viehbacher to run Swiss billionaire’s investment fund
One of our favorite bio-celebrities is enlarging his CV with a new job position. The…
June 23, 2015 - 2 minutes
Will Boehringer Ingelheim win the race for anticoagulants?
Boehringer Ingelheim has released the last figures of its idarucizumab Phase III. The breakthrough anti-anticoagulant…
June 23, 2015 - 2 minutes
Kamada and Baxter extend their collaboration in Lung Transplant
The Israeli biotech Kamada and Baxalta, Baxter’ subsidiary will jointly co-fund a trial test to find…
June 22, 2015 - 1 minute
A Dutch entrepreneur curing his ALS disease became BIO’s Superhero
Each year, BIO Philadelphia awards the Everyday Superheroes of Biotech Industry. Here's the story of…
June 22, 2015 - 3 minutes
Medigene plans to fund its T-cell program with €50 Millions
Munich-based Medigene is planning to raise cash through existing shareholders’ investments. The company targets up…
June 22, 2015 - 2 minutes
